Franck Carbonnel
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
2015/11/05 by Marie Vétizou, Jonathan M. Pitt, Romain Daillère +45 · 60 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Gut microbiota and health #Clostridium difficile and Clostridium perfringens research #Tryptophan and brain disorders
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2022/10/18 by J. Haanen, John B.A.G. Haanen, Michel Obéid +21 · 5 citations
Medicine · #Cancer Immunotherapy and Biomarkers #Drug-Induced Adverse Reactions #Colorectal Cancer Treatments and Studies
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
2018/04/12 by Julien Kirchgesner, Magali Lemaître, Magali Lemaitre +5 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Rheumatoid Arthritis Research and Therapies #Clostridium difficile and Clostridium perfringens research
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017/05/05 by John B.A.G. Haanen, J.B.A.G. Haanen, Franck Carbonnel +11 · 2 citations
Medicine · #CAR-T cell therapy research #Cancer Immunotherapy and Biomarkers #Colorectal Cancer Treatments and Studies
- Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
2017/01/04 by D Laharie, David Laharie, Arnaud Bourreille +57 · 25 citations
Medicine · Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Adrenal Hormones and Disorders #Inflammatory Bowel Disease #Immunodeficiency and Autoimmune Disorders